Molecular Diagnostics Market Research Report - Forecast till 2027

Molecular Diagnostics Market Research Report: Information By Product (Reagents & Kits, Instruments and Services & Software), Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray and others), Application (Infectious Diseases, Oncology, Genetic Tests and others), End User (Hospitals & Clinics, Diagnostic Laboratories and others) - Forecast till 2027

ID: MRFR/MED/0665-CR | February 2021 | Region: Global | 130 pages

Impact of COVID-19 on the Global Molecular Diagnostics Market 


The spread of COVID-19 worldwide has dramatically increased the number of suspected cases and the geographic areas where laboratory testing must be implemented and intensified. The molecular testing for COVID-19 has led to shortages of molecular testing reagents worldwide for COVID-19. Beyond supply issues, there are limitations of absorption capacity in several regions, especially in low- and middle-income countries.  


Testing remains a crucial step to control the rapid spread of the virus. With an increasing number of cases, governments across the world are exploring the opportunities of allowing private laboratories to ramp up testing. The wide availability of diagnostics will be required for the immediate detection of COVID-19 cases. The World Health Organization (WHO) has developed testing strategy recommendations as a part of the strategic preparedness and response plan. The foundation of this strategy includes:




  • Testing in regions with community transmission and in settings where the testing capacity cannot meet needs must be prioritized. It should focus on the early detection and protection of vulnerable patients and healthcare workers.




  • Focused testing in healthcare facilities helps ensure that infection prevention and control measures are effectively implemented so that vulnerable patients who do not have COVID-19 are safeguarded from nosocomial COVID-19 infection.




  • Testing among vulnerable populations and risk groups will be important for early treatment to minimize progression to severe disease.




Government Support:




  • On February 4th, 2020, the Food and Drug Administration (US FDA) issued a new policy to accelerate the availability of diagnostic services. A public health emergency was announced, justifying the authorization of the emergency use of in-vitro diagnostics (IVDs) for the diagnosis of COVID-19.




  • The US FDA has approved 20 manufacturers and kits for diagnostic testing for COVID-19.  For instance, on March 12th, 2020, Roche Diagnostics received the EUA (Emergency Use Authorization) for its novel coronavirus diagnostic test and cobasSARS-CoV-2 Test from the US FDA, which will be soon made available in India. 




  • In India, the Indian Council of Medical Research (ICMR) has approved 176 labs, including 47 private labs, to conduct the necessary tests. 




  • The European Commission decided to postpone the changes from Medical Device Directive (MDD) to Medical Device Regulation (MDR), which was expected to be implemented on May 26th, 2020, by a year. This enabled the medical device market and Notified Bodies (NBs) to focus on combating COVID-19.




  • Australia issued an exemption for devices involved in the diagnosis, confirmatory testing, prevention, monitoring, treatment, or alleviation of COVID-19.




Currently Available Testing Kits: Molecular assays and immunoassays are the most widely adopted diagnostics tests for COVID-19.  Furthermore, digital solutions are being developed to monitor and track the development of COVID-19. For instance, InferRead CT Pneumonia is being developed by Beijing-based Infervision Technology, which detects lesions from symptoms of pneumonia. Breath biomarkers that can detect and track the virus are currently being developed.


In conclusion, the molecular diagnostics market must keep up with demand, despite the factories of suppliers shutting down production, reduced factory working hours, limited workforce, and, often, the shutdown of research & development. It is certainly a challenge to introduce innovative new products in the market during these times. Several molecular assays and immunoassays are currently available to identify COVID-19. However, quality diagnostics, which provide faster and accurate test results, is the need of the hour. 

1 Executive Summary

2 Market Introduction

2.1 Definition 16

2.2 Scope of the Study 16

2.3 Assumptions & Limitations 16

2.3.1 Assumptions 16

2.3.2 Limitations 16

2.4 Market Structure 17

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 20

3.5 Forecast Model 21

4 Market Dynamics

4.1 Overview 22

4.2 Drivers 23

4.2.1 Rising Prevalence of Infectious Diseases 23

4.2.2 Advancements in Molecular Diagnostic Techniques 23

4.2.3 Rising Prevalence of Different Types of Cancer 23

4.3 Restraints 24

4.3.1 Stringent Regulatory Policies 24

4.4 Opportunities 25

4.4.1 Entering Developing Economies 25

4.5 Technology Trends & Assessment 25

5 Market Factor Analysis

5.1 Value Chain Analysis 26

5.1.1 R&D and Designing 26

5.1.2 Good Laboratory Practices 26

5.1.3 Molecular Diagnostics Testing 26

5.1.4 Distribution and Sales 27

5.1.5 Post-Sales Monitoring 27

5.2 Porter’s Five Forces Analysis 28

5.2.1 Bargaining Power of Suppliers 29

5.2.2 Bargaining Power of Buyers 29

5.2.3 Threat of New Entrants 29

5.2.4 Threat of Substitutes 30

5.2.5 Intensity of Rivalry 30

5.3 Investment Opportunities 30

5.4 Pricing Analysis 31

6 Molecular Diagnostics Market, By Product

6.1 Overview 32

6.2 Reagents & Kits 33

6.3 Instruments 34

6.4 Services & Software 34

7 Molecular Diagnostics Market, By Technique

7.1 Overview 35

7.2 Polymerase Chain Reaction (PCR) 36

7.3 Isothermal Amplification 37

7.4 Hybridization 37

7.5 Sequencing 38

7.6 Microarray 39

7.7 Others 39

8 Molecular Diagnostics Market, By Application

8.1 Overview 40

8.2 Infectious Diseases 41

8.3 Oncology 42

8.4 Genetic Tests 42

8.5 Others 43

9 Molecular Diagnostics Market, By End-User

9.1 Overview 44

9.2 Hospitals & Clinics 45

9.3 Diagnostic Laboratories 46

9.4 Others 46

10 Global Molecular Diagnostics Market, By Region

10.1 Overview 47

10.2 Americas 49

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.2.1 North America 51

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.2.1.1 US 53

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.2.1.2 Canada 54

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.2.2 Latin America 56

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3 Europe 57

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1 Western Europe 59

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.1 Germany 61

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.2 France 63

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.3 UK 64

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.4 Italy 65

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.5 Spain 67

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.1.6 Rest of Western Europe 68

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.3.2 Eastern Europe 69

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4 Asia-Pacific 71

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.1 Japan 73

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.2 China 74

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.3 India 76

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.4 South Korea 77

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.5 Australia 78

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.4.6 Rest of Asia-Pacific 80

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.5 Middle East & Africa 82

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.5.1 Middle East 84

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

10.5.2 Africa 85

Molecular Diagnostics Market, By Product

Molecular Diagnostics Market, By Technique

Molecular Diagnostics Market, By Application

Molecular Diagnostics Market, By End-User

11 Competitive Landscape

11.1 Overview 87

11.2 Company Share Analysis 87

11.3 Competitive Benchmarking 88

11.4 Leading Player in Terms of Number of Developments in the Molecular Diagnostics Market 89

11.5 Key Development Analysis 90

11.5.1 Partnership/Strategic Agreement 90

11.5.2 Acquisition 91

11.5.3 Product Approval 92

11.5.4 Product Launch 93

12 Company Profiles

12.1 F. Hoffmann-La Roche Ltd 94

12.1.1 Company Overview 94

12.1.2 Financial Overview 94

12.1.3 Products/Services Offered 95

12.1.4 Key Developments 95

12.1.5 SWOT Analysis 96

12.1.6 Key Strategies 96

12.2 Hologic, Inc. 97

12.2.1 Company Overview 97

12.2.2 Financial Overview 97

12.2.3 Products/Services Offered 98

12.2.4 Key Developments 98

12.2.5 SWOT Analysis 99

12.2.6 Key Strategies 99

12.3 Qiagen 100

12.3.1 Company Overview 100

12.3.2 Financial Overview 100

12.3.3 Products/Services Offered 101

12.3.4 Key Developments 101

12.3.5 SWOT Analysis 101

12.3.6 Key Strategies 102

12.4 Becton, Dickinson, and Company 103

12.4.1 Company Overview 103

12.4.2 Financial Overview 103

12.4.3 Products/Services Offered 104

12.4.4 Key Developments 104

12.4.5 SWOT Analysis 104

12.4.6 Key Strategies 105

12.5 Abbott Laboratories 106

12.5.1 Company Overview 106

12.5.2 Financial Overview 106

12.5.3 Products/Services Offered 107

12.5.4 Key Developments 108

12.5.5 SWOT Analysis 108

12.5.6 Key Strategies 108

12.6 Cepheid 109

12.6.1 Company Overview 109

12.6.2 Financial Overview 109

12.6.3 Products/Services Offered 110

12.6.4 Key Developments 111

12.6.5 SWOT Analysis 111

12.6.6 Key Strategies 111

12.7 Siemens 112

12.7.1 Company Overview 112

12.7.2 Financial Overview 112

12.7.3 Products/Services Offered 113

12.7.4 Key Developments 113

12.7.5 SWOT Analysis 113

12.7.6 Key Strategies 113

12.8 CLONIT srl 114

12.8.1 Company Overview 114

12.8.2 Financial Overview 114

12.8.3 Products/Services Offered 114

12.8.4 Key Developments 115

12.8.5 SWOT Analysis 116

12.8.6 Key Strategies 116

12.9 Thermo Fisher Scientific Inc. 117

12.9.1 Company Overview 117

12.9.2 Financial Overview 117

12.9.3 Products Offering 118

12.9.4 Key Developments 118

12.9.5 SWOT Analysis 118

12.9.6 Key Strategies 118

12.10 Agilent Technologies 119

12.10.1 Company Overview 119

12.10.2 Financial Overview 119

12.10.3 Products/Services Offered 120

12.10.4 Key Developments 120

12.10.5 SWOT Analysis 120

12.10.6 Key Strategies 121

12.11 EKF Diagnostics 122

12.11.1 Company Overview 122

12.11.2 Financial Overview 122

12.11.3 Products/Services Offered 122

12.11.4 Key Developments 123

12.11.5 SWOT Analysis 123

12.11.6 Key Strategies 123

12.12 Novartis 124

12.12.1 Company Overview 124

12.12.2 Financial Overview 124

12.12.3 Products/Services Offered 124

12.12.4 Key Developments 125

12.12.5 SWOT Analysis 125

12.12.6 Key Strategies 125

12.13 Illumina 126

12.13.1 Company Overview 126

12.13.2 Financial Overview 126

12.13.3 Products/Services Offered 127

12.13.4 Key Developments 127

12.13.5 SWOT Analysis 127

12.13.6 Key Strategies 128

13 Appendix

13.1 References 129

13.2 Related Reports 129

14 List of Tables

TABLE 1 MARKET SYNOPSIS 15

TABLE 2 PRIMARY INTERVIEWS 19

TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 32

TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR REAGENTS & KITS, BY REGION, 2020–2027 (USD MILLION) 33

TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 35

TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2020–2027 (USD MILLION) 36

TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ISOTHERMAL AMPLIFICATION, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HYBRIDIZATION, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SEQUENCING, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR MICROARRAY, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 40

TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR GENETIC TESTS, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 44

TABLE 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 24 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 25 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 50

TABLE 26 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 50

TABLE 27 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 50

TABLE 28 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 51

TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 51

TABLE 30 NORTH AMERICA: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020 (%) 51

TABLE 31 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 52

TABLE 32 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 52

TABLE 33 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 52

TABLE 34 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 53

TABLE 35 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 53

TABLE 36 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 53

TABLE 37 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

TABLE 38 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 54

TABLE 39 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 54

TABLE 40 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 55

TABLE 41 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

TABLE 42 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 55

TABLE 43 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 56

TABLE 44 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 56

TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 46 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 57

TABLE 47 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 58

TABLE 49 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 58

TABLE 50 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 51 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 59

TABLE 52 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 59

TABLE 53 WESTERN EUROPE: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020 (%) 60

TABLE 54 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60

TABLE 55 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 60

TABLE 56 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 57 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 61

TABLE 58 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 61

TABLE 59 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 62

TABLE 60 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 61 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 62 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 63

TABLE 63 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 63

TABLE 64 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 65 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 66 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 64

TABLE 67 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 64

TABLE 68 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 69 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 70 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65

TABLE 71 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 66

TABLE 72 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 73 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 74 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 67

TABLE 75 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 67

TABLE 76 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 77 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 68

TABLE 78 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68

TABLE 79 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 68

TABLE 80 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69

TABLE 81 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 82 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 69

TABLE 83 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 70

TABLE 84 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 85 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 86 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 71

TABLE 87 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020 (%) 71

TABLE 88 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72

TABLE 89 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 72

TABLE 90 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 91 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 92 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 73

TABLE 93 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 73

TABLE 94 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 95 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 96 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74

TABLE 97 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 75

TABLE 98 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 99 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 75

TABLE 100 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 76

TABLE 101 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 76

TABLE 102 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 103 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 77

TABLE 104 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77

TABLE 105 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 77

TABLE 106 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 107 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 78

TABLE 108 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78

TABLE 109 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 79

TABLE 110 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 111 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 112 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

TABLE 113 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 80

TABLE 114 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 115 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 116 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 82

TABLE 117 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 83

TABLE 118 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 83

TABLE 119 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 120 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 121 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 84

TABLE 122 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 84

TABLE 123 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85

TABLE 124 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 85

TABLE 125 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

TABLE 126 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 86

TABLE 127 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 128 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 86

TABLE 129 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MOLECULAR DIAGNOSTICS MARKET 89

TABLE 130 PARTNERSHIP/STRATEGIC AGREEMENT 90

TABLE 131 ACQUISITION 91

TABLE 132 MERGER & ACQUISITION 92

TABLE 133 PRODUCT LAUNCH 93

15 List of Figures

FIGURE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET: MARKET STRUCTURE 17

FIGURE 2 RESEARCH PROCESS 18

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 21

FIGURE 4 DRIVERS: IMPACT ANALYSIS 24

FIGURE 5 RESTRAINTS: IMPACT ANALYSIS 24

FIGURE 6 VALUE CHAIN: GLOBAL MOLECULAR DIAGNOSTICS MARKET 26

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MOLECULAR DIAGNOSTICS MARKET 28

FIGURE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2020 (%) 32

FIGURE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 33

FIGURE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY TECHNIQUE, 2020 (%) 35

FIGURE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2020 & 2027 (USD MILLION) 36

FIGURE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2020 (%) 40

FIGURE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 41

FIGURE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY END USER, 2020 (%) 44

FIGURE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020 & 2027 (USD MILLION) 45

FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2020 (%) 47

FIGURE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 48

FIGURE 18 AMERICAS: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2020 (%) 49

FIGURE 19 EUROPE: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2020 (%) 58

FIGURE 20 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2020 (%) 82

FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS 2020 (%) 88

FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS 88

FIGURE 23 MOLECULAR DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (% SHARE) 90